Literature DB >> 8101699

Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides.

C Tiruppathi1, Y Miyamoto, V Ganapathy, F H Leibach.   

Abstract

The functional role of dipeptidyl peptidase IV (DPP IV) in the intestinal hydrolysis and assimilation of prolyl peptides was investigated using Japan F344 rats, which genetically lack this enzyme. USA F344 rats possess normal activity of this enzyme and served as matched controls. Intestinal brush-border membranes from the control rats were able to hydrolyze several proline-containing peptides. The hydrolytic ability of the brush-border membranes from the Japan rats against these peptides was markedly low. The difference in the hydrolytic activities between the two groups of rats was solely due to the absence of DPP IV in the Japan rats. There was no difference in the growth rate between the two groups of rats fed a reference diet whose protein constituents were not rich in proline. When the protein source was changed to gliadin, a proline-rich protein, USA F344 rats maintained their body weight for a 4-wk period on this diet, whereas the Japan rats experienced a significant weight loss under similar conditions. In situ perfusion experiments in intact animals revealed that the ability of morphiceptin (a peptide primarily hydrolyzable by DPP IV), when administered into the intestinal lumen, to block the cholera toxin-induced water secretion was significantly greater in Japan F344 rats than in USA F344 rats, indicating the resistance of morphiceptin to hydrolytic breakdown in the intestinal lumen of the Japan rats. It is concluded that the intestinal DPP IV plays a significant role in the hydrolysis of prolyl peptides and assimilation of proline-rich proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101699     DOI: 10.1152/ajpgi.1993.265.1.G81

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.

Authors:  Roger Yazbeck; Simone E Jaenisch; Catherine A Abbott
Journal:  Protoplasma       Date:  2017-06-16       Impact factor: 3.356

2.  Brush border enzyme activities in the small intestine after long-term gliadin feeding in animal models of human coeliac disease.

Authors:  H Kozáková; R Stĕpánková; J Kolínská; M A Farré; D P Funda; L Tucková; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

3.  Identification of bile canalicular cell surface antigen HAM.4 as dipeptidyl peptidase IV (DPPIV) and characterization of its role in hepatic regeneration after partial hepatectomy in rats.

Authors:  M Tsugiki; Y Kobayashi; T Kawasaki; T Yoshimi
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

4.  The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

Authors:  E Richard; F X Arredondo-Vega; I Santisteban; S J Kelly; D D Patel; M S Hershfield
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

5.  A Comprehensive Evaluation of the Impact of Bovine Milk Containing Different Beta-Casein Profiles on Gut Health of Ageing Mice.

Authors:  Barbara Guantario; Marzia Giribaldi; Chiara Devirgiliis; Alberto Finamore; Elena Colombino; Maria Teresa Capucchio; Rocchina Evangelista; Vincenzo Motta; Paola Zinno; Simona Cirrincione; Sara Antoniazzi; Laura Cavallarin; Marianna Roselli
Journal:  Nutrients       Date:  2020-07-19       Impact factor: 5.717

6.  Development of a 13C Stable Isotope Assay for Dipeptidyl Peptidase-4 Enzyme Activity A New Breath Test for Dipeptidyl Peptidase Activity.

Authors:  Roger Yazbeck; Simone Jaenisch; Michelle Squire; Catherine A Abbott; Emma Parkinson-Lawrence; Douglas A Brooks; Ross N Butler
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

Review 7.  Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.

Authors:  Erin E Mulvihill; Daniel J Drucker
Journal:  Endocr Rev       Date:  2014-09-12       Impact factor: 19.871

8.  In Silico Approaches Applied to the Study of Peptide Analogs of Ile-Pro-Ile in Relation to Their Dipeptidyl Peptidase IV Inhibitory Properties.

Authors:  Alice B Nongonierma; Luca Dellafiora; Sara Paolella; Gianni Galaverna; Pietro Cozzini; Richard J FitzGerald
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-14       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.